|
|
|
Volumn 7, Issue 3, 1996, Pages 395-399
|
|
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma
|
|
Author keywords
Dose intensity; MVAC; Previously untreated urothelial carcinoma; RhG CSF
|
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINBLASTINE;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BLADDER CARCINOMA;
BONE MARROW TOXICITY;
BONE PAIN;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
CYSTECTOMY;
FEMALE;
FEVER;
HUMAN;
MALE;
MUCOSA INFLAMMATION;
NAUSEA;
NEUTROPENIA;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
CYSTECTOMY;
DOXORUBICIN;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INFECTION;
MALE;
METHOTREXATE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEUTROPENIA;
RECOMBINANT PROTEINS;
STOMATITIS;
THROMBOCYTOPENIA;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
|
|
EID: 0029743114
PISSN: 11485493
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (2)
|
